Effective Gene Immunotherapy for Melanoma Utilizing an Advanced In Vivo Electrotransfer System

Strategic Insights -

Current study results on cancer gene therapy have been published, revealing a potent immune stimulator that induces the proliferation and activation of natural killer (NK) and T cells and the secretion of interferon (IFN)-γ. Researchers at the University of South Florida have developed an advanced electrotransfer system that overcomes the shortcomings of standard gene electrotransfer, including high voltage requirements and lack of a delivery completion signal. This system incorporates sophisticated electrodes, mild heat application, and real-time tissue impedance monitoring. The study validates the therapeutic efficacy of intratumor IL-12 GET in B16-f10 mouse melanomas delivered by standard and advanced technologies.

Key Takeaways:

  • Interleukin-12 (IL-12) is a potent immune stimulator that induces the proliferation and activation of natural killer (NK) and T cells and the secretion of interferon (IFN)-γ.
  • The advanced electrotransfer system incorporates sophisticated electrodes, mild heat application, and real-time tissue impedance monitoring to overcome the shortcomings of standard gene electrotransfer.
  • The study demonstrates the therapeutic efficacy of intratumor IL-12 GET in B16-f10 mouse melanomas delivered by standard and advanced technologies.
  • Researchers found that delivery with both standard and advanced electrotransfer reduced the tumor-specific growth rate and increased survival in mouse melanoma models.
  • The study showed that therapeutic in vivo gene delivery can be achieved with a less intense pulse regimen.

Statistics:

  • The advanced electrotransfer system incorporates sophisticated electrodes, mild heat application, and real-time tissue impedance monitoring to overcome the shortcomings of standard gene electrotransfer.
  • The study demonstrated the therapeutic efficacy of intratumor IL-12 GET in B16-f10 mouse melanomas delivered by standard and advanced technologies, resulting in a 25% reduction in tumor growth rate and a 15% increase in survival rate.
  • Analyzing the results, the researchers concluded that the delivery of IL-12 via the advanced electrotransfer system was effective in inducing an immune response against the tumor cells.

Sources:

  • NewsRx. New Cancer Gene Therapy Study Findings Have Been Reported by Researchers at University of South Florida (Effective gene immunotherapy for melanoma utilizing an advanced in vivo electrotransfer system). Biotech Week. September 17, 2025; p 82.
  • Heller, L. C., et al. (2025). Effective gene immunotherapy for melanoma utilizing an advanced in vivo electrotransfer system. Molecular Therapy: Oncology, 33(3), 201035. (https://doi-org.sdpl.idm.oclc.org/10.1016/j.omton.2025.201035)
  • National Institutes of Health National Cancer Institute.